These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9380298)

  • 41. Is 1 mg of estradiol valerate or 0.625 mg of conjugated estrogens sufficient for all women to prevent menopausal bone loss?
    Duursma SA; de Raadt M; Raymakers JA; Haspels AA
    Gynecol Endocrinol; 1992 Sep; 6(3):205-9. PubMed ID: 1332428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term estrogen replacement therapy prevents bone loss and fractures.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1985 Mar; 102(3):319-24. PubMed ID: 2982302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current perspective in the management of menopausal and postmenopausal women.
    Dumesic DA
    J Clin Pharmacol; 1992 Sep; 32(9):774-8. PubMed ID: 1331204
    [No Abstract]   [Full Text] [Related]  

  • 44. [Problems with bone densitometry].
    Dambacher MA; Felder M; Keller A; Neff M
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):79-83. PubMed ID: 8296135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limitations of bone densitometry.
    Heidrich F
    Am Fam Physician; 1993 Jul; 48(1):25-7. PubMed ID: 8322638
    [No Abstract]   [Full Text] [Related]  

  • 46. [Osteoporosis, estrogens, and bone metabolism. Implications for chronic renal insufficiency].
    Díaz López JB; Rodríguez Rodríguez A; Ramos B; Caramelo C; Rodríguez García M; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():78-83. PubMed ID: 12778860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Normal ranges and quality assurance for dual energy X-ray absorptiometry scanning].
    Abrahamsen B; Sørensen HA; Rud B; Hermann AP; Jensen JE; Mølgaard C; Sørensen OH
    Ugeskr Laeger; 2005 Feb; 167(8):878-82. PubMed ID: 15789839
    [No Abstract]   [Full Text] [Related]  

  • 48. [Estrogen replacement therapy for postmenopausal osteoporosis].
    Lessing J; Glazer E; Peyser MR
    Harefuah; 1986 Oct; 111(7-8):186-8. PubMed ID: 3026935
    [No Abstract]   [Full Text] [Related]  

  • 49. Recommended age for testing for osteoporosis in women.
    Muncie HL
    Am Fam Physician; 2010 Feb; 81(3):252. PubMed ID: 20112881
    [No Abstract]   [Full Text] [Related]  

  • 50. Conjugated Estrogens/Bazedoxifene (Duavee) for Menopausal Symptoms.
    Johnson K; Hauck F
    Am Fam Physician; 2016 Feb; 93(4):307-14. PubMed ID: 26926819
    [No Abstract]   [Full Text] [Related]  

  • 51. New low-dose estrogen approved for prevention of postmenopausal osteoporosis.
    AWHONN Lifelines; 2003; 7(5):457-8. PubMed ID: 14710717
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.
    Bilezikian JP; Morishima A; Bell J; Grumbach MM
    N Engl J Med; 1998 Aug; 339(9):599-603. PubMed ID: 9718379
    [No Abstract]   [Full Text] [Related]  

  • 53. [Post-menopausal osteoporosis. A true and real social disease].
    Grio R; Piacentino R; Corsello FP; Aricchiello G; Canestrelli M; Fusi D; Marchino GL
    Minerva Ginecol; 1991 Dec; 43(12):561-3. PubMed ID: 1819773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin D treatment and bone mineral density in the aged.
    Heikinheimo R; Sievänen H; Jäntti P; Mäki-Jokela PL; Rajala S; Vuori I
    Maturitas; 1996 May; 23 Suppl():S77-80. PubMed ID: 8865145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention and treatment of the involutional osteoporosis in the elderly].
    Zhu JM
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):653. PubMed ID: 7712907
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of postmenopausal osteoporosis.
    Reginster JY
    BMJ; 2005 Apr; 330(7496):859-60. PubMed ID: 15831851
    [No Abstract]   [Full Text] [Related]  

  • 57. Calcitonin in the treatment of osteoporosis.
    Gennari C; Camporeale A
    Osteoporos Int; 1997; 7 Suppl 3():S159-62. PubMed ID: 9536324
    [No Abstract]   [Full Text] [Related]  

  • 58. Perspectives on osteoporosis.
    Kaltenborn KC
    Clin Obstet Gynecol; 1992 Dec; 35(4):901-12. PubMed ID: 1451373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health.
    Kaste SC; Chesney RW; Hudson MM; Lustig RH; Rose SR; Carbone LD
    J Bone Miner Res; 1999 Dec; 14(12):2010-4. PubMed ID: 10620059
    [No Abstract]   [Full Text] [Related]  

  • 60. Estrogen replacement therapy and osteoporosis.
    Gambrell RD
    Hosp Pract (Off Ed); 1991; 26 Suppl 1():30-5. PubMed ID: 1898511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.